Project HoTT - 38.121 monitoring
|Project designation: HoTT - Horse Testing Tour||Approval date: 27-12-2019|
|Project code: Centro-01-0247-FEDER-38.121||Start date: 30-11-2019|
|Main objective: Strengthening research, technological development and innovation||Conclusion date: 30-11-2022|
|Intervention region: PO_Centro||Total eligible amount: 368.765,90€|
|Beneficiary entity: Equigerminal, S.A.||Total approved amount: PT_2020_FEDER: 235.314,11€|
| Project summary:
The HoTT-Horse Testing Tour project - is the culmination of successfully completed R & D activities in the generation of disruptive, patented and certified diagnostic kits under the projects QREN I & DT No18536, No38637, PT2020 PI 17196 and PT2020 ID & T 10991. With this demonstrator project we intend, for the first time, to enter the market and reach the long-awaited goal - the commercialisation of innovative diagnostic kits for the New Equine Virus (NEV).
The global equestrian industry is a multibillion-dollar marketplace that encompasses many equestrian activities, such as the racing industry, sport and leisure horses. It is a niche market and very demanding.
During the years 2020/2021 HoTT will demonstrate and disseminate Equigerminal diagnostic kits in the European market (UK, Germany, France and Italy), the Middle East and Brazil, with the main objective of validating the kits in real environment and to create a network of laboratories validated for the diagnosis of NEV.
| Main objectives: